Literature DB >> 4214774

Inhibition of Pseudomonas aeruginosa by hyperbaric oxygen: interaction with mouse peritoneal exudate cells.

O S Weislow, L M Pakman.   

Abstract

High-pressure oxygen (HPO) therapy for Pseudomonas aeruginosa infections of burn wounds has not been as effective as in vitro studies predicted. Mitigation of HPO toxicity for P. aeruginosa by nutrients present at the burn site could explain the lack of in vivo success. Alternatively, HPO-induced depression of host defense mechanisms could negate beneficial effects arising from HPOs known toxicity for P. aeruginosa. Accordingly, mouse peritoneal exudate cells (PEC), preincubated for 24 h in 1 atm of air-CO(2), were used to study the in vitro effects of HPO or air-CO(2) on phagocytosis of P. aeruginosa or sheep erythrocytes (SRBC). Subsequent 2-h exposures of PEC to increasing numbers of bacteria, in an air-CO(2) atmosphere, decreased the percentage of bacteria cleared as well as PEC viability. Similar exposures of PEC to bacteria in an HPO atmosphere prevented the loss of PEC viability and increased bacterial clearance. In control experiments, increasing the number of SRBC relative to PEC decreased the percentage of SRBC cleared without decreasing PEC viability, as determined under air-CO(2); short (2 h) exposure to HPO did not affect SRBC clearance. Microscopic examination of PEC indicated that a 24-h preincubation in HPO decreased the percentage of PEC which could ingest SRBC during subsequent experimental exposures (2 h) to air-CO(2) or HPO. These data suggest that short periods of exposure to HPO promote the ability of PEC to clear pseudomonads by adversely affecting the bacteria. This in turn prevents a pseudomonad-induced depression of PEC viability and function. In contrast, prolonged HPO exposure may be detrimental to phagocytic activity.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4214774      PMCID: PMC422989          DOI: 10.1128/iai.10.3.546-552.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Effect of hyperbaric oxygen on aerobic bacteria in vitro and in vivo.

Authors:  D Kaye
Journal:  Proc Soc Exp Biol Med       Date:  1967-04

2.  Exposure of Pseudomonas aeruginosa to hyperbaric oxygen: inhibited growth and enhanced activity of polymyxin B.

Authors:  G H Bornside
Journal:  Proc Soc Exp Biol Med       Date:  1967 Aug-Sep

Review 3.  Cellular mechanisms of oxygen toxicity.

Authors:  N Haugaard
Journal:  Physiol Rev       Date:  1968-04       Impact factor: 37.312

4.  The lethal events in experimental Pseudomonas aeruginosa infection of mice.

Authors:  P F Bartell; T E Orr; M Garcia
Journal:  J Infect Dis       Date:  1968-04       Impact factor: 5.226

5.  Effect of thermal injury upon the early resistance to infection.

Authors:  J W Alexander
Journal:  J Surg Res       Date:  1968-03       Impact factor: 2.192

Review 6.  Hyperbaric oxygenation.

Authors:  H E Chew; G C Hanson; W K Slack
Journal:  Br J Dis Chest       Date:  1969-07

7.  Oxygen gradients in healing wounds.

Authors:  J P Remensnyder; G Majno
Journal:  Am J Pathol       Date:  1968-02       Impact factor: 4.307

8.  Experimental studies on local treatment of pseudomonas-infected burn wounds.

Authors:  H E Koehnlein; G Lemperle
Journal:  Plast Reconstr Surg       Date:  1970-06       Impact factor: 4.730

9.  Lethal factors in Pseudomonas aeruginosa.

Authors:  K G Narayan; A K Prasad; C P Srivastava
Journal:  Indian Vet J       Date:  1970-02

10.  The localization by electron microscopy of nucleoside phosphatase activity in guinea pig phagocytic cells.

Authors:  R J North
Journal:  J Ultrastruct Res       Date:  1966-09
View more
  3 in total

1.  Early hyperbaric oxygen therapy improves survival in a model of severe sepsis.

Authors:  Jonathan L Halbach; James M Prieto; Andrew W Wang; Dennis Hawisher; David M Cauvi; Tony Reyes; Jonathan Okerblom; Israel Ramirez-Sanchez; Francisco Villarreal; Hemal H Patel; Stephen W Bickler; George A Perdrizet; Antonio De Maio
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-15       Impact factor: 3.619

2.  Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19?

Authors:  Anders Kjellberg; Antonio De Maio; Peter Lindholm
Journal:  Med Hypotheses       Date:  2020-08-30       Impact factor: 1.538

Review 3.  Potential Advances of Adjunctive Hyperbaric Oxygen Therapy in Infective Endocarditis.

Authors:  Christian Johann Lerche; Franziska Schwartz; Mia Marie Pries-Heje; Emil Loldrup Fosbøl; Kasper Iversen; Peter Østrup Jensen; Niels Høiby; Ole Hyldegaard; Henning Bundgaard; Claus Moser
Journal:  Front Cell Infect Microbiol       Date:  2022-02-03       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.